Neuland Laboratories Ltd.
Snapshot View

1404.05 -46.40 ▼-3.2%

30 January 2023, 04:01:00 PM
Volume: 6,078

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.neulandlabs.com
Market Cap 1,819.92 Cr.
Enterprise Value(EV) 1,981.91 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 64.80 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 21.67 Trailing Twelve Months Ending 2022-09
Industry PE 32.78 Trailing Twelve Months Ending 2022-09
Book Value / Share 687.25 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.04 Calculated using Price: 1,404.05
Dividend Yield 0.35 Period Ending 2022-03
No. of Shares Subscribed 1.28 Cr. 12,829,889 Shares
FaceValue 10
Company Profile
Neuland is a quality conscious, research driven, reliable source of active pharmaceutical ingredients. Neuland has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions. Safety aspects have been given utmost significance may it be plant installation, equipment, systems and personnel to ensure smooth productivity. Dedicated team of manufacturing with incorporation of latest production techniques guarantees delivery of latest intermediate and product to our customers across the globe.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.20%
1 Week
-8.81%
1 Month
-15.85%
3 Month
-4.93%
6 Month
+8.57%
1 Year
-4.77%
2 Year
+9.12%
5 Year
+66.97%
10 Year
+1019.39%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 24.14 11.24 15.64 22.34 5.02 3.48 2.30 10.79 7.85
Return on Capital Employed (%) 18.99 15.75 18.57 15.98 4.07 3.99 7.85 12.81 9.44
Return on Assets (%) 5.89 3.20 5.23 6.65 1.23 1.49 1.37 6.31 4.71

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 124 161 187 546 558 699 710 786 841 883
Non Curr. Liab. 52 55 69 54 146 104 163 170 180 164
Curr. Liab. 307 295 268 286 367 327 358 369 363 378
Minority Int. 0 0
Equity & Liab. 483 512 524 886 1,071 1,130 1,231 1,325 1,383 1,424
Non Curr. Assets 196 196 210 511 624 677 716 775 801 805
Curr. Assets 288 316 314 375 447 453 515 550 583 620
Misc. Exp. not W/O
Total Assets 483 512 524 886 1,071 1,130 1,231 1,325 1,383 1,424

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 466 469 510 579 527 667 763 937 951 1,007
Other Income 3 1 2 1 5 3 4 16 2 3
Total Income 469 470 512 580 532 670 767 953 953 1,011
Total Expenditure -395 -403 -430 -473 -477 -608 -661 -790 -808 -838
PBIDT 74 67 82 108 55 62 106 163 145 172
Interest -25 -27 -24 -21 -19 -16 -22 -18 -14 -12
Depreciation -15 -15 -16 -19 -22 -26 -31 -40 -49 -51
Taxation -8 -9 -15 -20 -2 -4 -37 -25 -18 -26
Exceptional Items
PAT 27 16 27 47 12 16 16 81 64 83
Minority Interest 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 27 16 27 47 12 16 16 81 64 83
Adjusted EPS 33 18 31 53 14 13 13 63 50 64

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 26 49 13 45 39 11 70 57 189 59
Cash Fr. Inv. -7 -10 -14 -20 -42 -116 -77 -49 -84 -94
Cash Fr. Finan. -20 -39 1 -24 0 105 12 -5 -114 38
Net Change -1 0 0 1 -4 0 5 3 -9 3
Cash & Cash Eqvt 1 1 1 2 3 3 8 11 2 5

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 36.25 36.22 36.22 36.22 36.22 36.22 36.22 36.22 36.14
Public 63.75 63.78 63.78 63.78 63.78 63.78 63.78 63.78 63.86
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 4.30 4.30 4.30 4.30 4.30 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 20 Jan 2023
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2022
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2022
Thu, 05 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Fri, 30 Dec 2022
Closure of Trading Window
Closure of Trading Window

Technical Scans View Details >>

Mon, 30 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On Neuland Laboratories Ltd.

What is Neuland Laboratories share price?

Can I buy Neuland Laboratories shares now?

What is the Dividend Yield of Neuland Laboratories?

What is the Market Cap of Neuland Laboratories?

What are the key metrics to analyse Neuland Laboratories?

What is the 52 Week High and Low of Neuland Laboratories?

What is the trend of Neuland Laboratories share price?